Re: Safety and Efficacy of Virtual Prostatectomy with Single-dose Radiotherapy in Patients with Intermediate-risk Prostate Cancer: Results from the PROSINT Phase 2 Randomized Clinical Trial
- PMID: 34518023
- DOI: 10.1016/j.eururo.2021.08.020
Re: Safety and Efficacy of Virtual Prostatectomy with Single-dose Radiotherapy in Patients with Intermediate-risk Prostate Cancer: Results from the PROSINT Phase 2 Randomized Clinical Trial
Comment in
-
Urological Oncology: Prostate Cancer.J Urol. 2021 Nov;206(5):1329-1331. doi: 10.1097/JU.0000000000002174. Epub 2021 Aug 18. J Urol. 2021. PMID: 34406073 No abstract available.
Comment on
-
Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical Trial.JAMA Oncol. 2021 May 1;7(5):700-708. doi: 10.1001/jamaoncol.2021.0039. JAMA Oncol. 2021. PMID: 33704378 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
